Search details
1.
Prostate Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(3): 140-150, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38626801
2.
Bladder Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(4): 216-225, 2024 05.
Article
in English
| MEDLINE | ID: mdl-38754471
3.
Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic.
J Behav Med
; 47(3): 405-421, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38418709
4.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(10): 1067-1096, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37856213
5.
Factors associated with changes in exercise behaviors during the COVID-19 pandemic.
Cancer Causes Control
; 33(7): 939-950, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35554777
6.
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
J Natl Compr Canc Netw
; 20(12): 1288-1298, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36509074
7.
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
J Natl Compr Canc Netw
; 20(8): 866-878, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35948037
8.
Technical note: Evaluation of a silicone-based custom bolus for radiation therapy of a superficial pelvic tumor.
J Appl Clin Med Phys
; 23(4): e13538, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35084098
9.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
BJU Int
; 128(5): 607-614, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33909949
10.
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 19(2): 134-143, 2021 02 02.
Article
in English
| MEDLINE | ID: mdl-33545689
11.
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(3): 329-354, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32135513
12.
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(5): 479-505, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-31085757
13.
Calculation of delivered composite dose from Calypso tracking data for prostate cancer: And subsequent evaluation of reasonable treatment interruption tolerance limits.
J Appl Clin Med Phys
; 20(8): 105-113, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31355998
14.
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
J Natl Compr Canc Netw
; 16(9): 1041-1053, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30181416
15.
Orgasmic Function after Radical Prostatectomy.
J Urol
; 198(2): 407-413, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28322856
16.
Urinary Diversion for Severe Urinary Adverse Events of Prostate Radiation: Results from a Multi-Institutional Study.
J Urol
; 197(3 Pt 1): 744-750, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27810450
17.
Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer.
BJU Int
; 119(5): 700-708, 2017 05.
Article
in English
| MEDLINE | ID: mdl-27469289
18.
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(10): 1240-1267, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28982750
19.
Prostate Cancer, Version 1.2016.
J Natl Compr Canc Netw
; 14(1): 19-30, 2016 01.
Article
in English
| MEDLINE | ID: mdl-26733552
20.
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
J Natl Compr Canc Netw
; 14(10): 1213-1224, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27697976